Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
2003 1
2004 7
2005 5
2006 4
2007 7
2008 6
2009 5
2010 6
2011 4
2012 5
2013 11
2014 5
2015 8
2016 5
2017 3
2018 1
2019 2
2021 3
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Acute cannabidiol treatment enhances social interaction in adult male mice.
Ferreira LF, Pathapati N, Schultz ST, Nunn MC, Pierce BL, Sanchez YR, Murrell MD, Ginsburg BC, Onaivi ES, Gould GG. Ferreira LF, et al. Among authors: schultz st. Adv Drug Alcohol Res. 2023;3:11163. doi: 10.3389/adar.2023.11163. Epub 2023 May 10. Adv Drug Alcohol Res. 2023. PMID: 37273836 Free PMC article.
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
Dimopoulos MA, Richardson PG, Bahlis NJ, Grosicki S, Cavo M, Beksaç M, Legieć W, Liberati AM, Goldschmidt H, Belch A, Magen H, Larocca A, Laubach JP, Petrucci MT, Reece D, White D, Mateos MV, Špička I, Lazaroiu M, Berdeja J, Kaufman JL, Jou YM, Ganetsky A, Popa McKiver M, Lonial S, Weisel K; ELOQUENT-1 investigators. Dimopoulos MA, et al. Lancet Haematol. 2022 Jun;9(6):e403-e414. doi: 10.1016/S2352-3026(22)00103-X. Epub 2022 May 9. Lancet Haematol. 2022. PMID: 35550060 Clinical Trial.
Editorial: Antioxidants in Autism Spectrum Disorders.
Bonomini F, Siniscalco D, Schultz S, Carnovale C, Barthélémy C, Fazzi EM. Bonomini F, et al. Among authors: schultz s. Front Psychiatry. 2022 Apr 7;13:889865. doi: 10.3389/fpsyt.2022.889865. eCollection 2022. Front Psychiatry. 2022. PMID: 35463522 Free PMC article. No abstract available.
Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
Robinson-Agramonte MLA, Noris García E, Fraga Guerra J, Vega Hurtado Y, Antonucci N, Semprún-Hernández N, Schultz S, Siniscalco D. Robinson-Agramonte MLA, et al. Among authors: schultz s. Int J Mol Sci. 2022 Mar 11;23(6):3033. doi: 10.3390/ijms23063033. Int J Mol Sci. 2022. PMID: 35328471 Free PMC article. Review.
Impact of SARS-CoV-2 on neuropsychiatric disorders.
Robinson-Agramonte MA, Gonçalves CA, Noris-García E, Préndes Rivero N, Brigida AL, Schultz S, Siniscalco D, García García RJ. Robinson-Agramonte MA, et al. Among authors: schultz s. World J Psychiatry. 2021 Jul 19;11(7):347-354. doi: 10.5498/wjp.v11.i7.347. eCollection 2021 Jul 19. World J Psychiatry. 2021. PMID: 34327127 Free PMC article. Review.
SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis.
Diaz de la Fe A, Peláez Suárez AA, Fuentes Campos M, Cabrera Hernández MN, Goncalves CA, Schultz S, Siniscalco D, Robinson-Agramonte MA. Diaz de la Fe A, et al. Among authors: schultz s. Diseases. 2021 Apr 19;9(2):32. doi: 10.3390/diseases9020032. Diseases. 2021. PMID: 33921878 Free PMC article. Review.
Speech-Stimulating Substances in Autism Spectrum Disorders.
Castillo MA, Urdaneta KE, Semprún-Hernández N, Brigida AL, Antonucci N, Schultz S, Siniscalco D. Castillo MA, et al. Among authors: schultz s. Behav Sci (Basel). 2019 Jun 12;9(6):60. doi: 10.3390/bs9060060. Behav Sci (Basel). 2019. PMID: 31212856 Free PMC article. Review.
91 results